TEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Teva Pharmaceutical Industries Ltd's quarterly cash and cash equivalents declined from Sep. 2013 ($1,148 Mil) to Dec. 2013 ($1,038 Mil) and declined from Dec. 2013 ($1,038 Mil) to Mar. 2014 ($901 Mil).
Teva Pharmaceutical Industries Ltd's annual cash and cash equivalents increased from Dec. 2011 ($1,096 Mil) to Dec. 2012 ($2,879 Mil) but then declined from Dec. 2012 ($2,879 Mil) to Dec. 2013 ($1,038 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Teva Pharmaceutical Industries Ltd Annual Data
Teva Pharmaceutical Industries Ltd Quarterly Data